Performance of breast cancer risk assessment models in a large mammography cohort.

Background Several breast cancer risk assessment models exist. Few studies have evaluated predictive accuracy of multiple models in large screening populations. Methods We evaluated the performance of the BRCAPRO, Gail, Claus, Breast Cancer Surveillance Consortium (BCSC) and Tyrer-Cuzick models in predicting risk of breast cancer over six years among 35,921 women aged 40-84 who underwent mammography screening at Newton-Wellesley Hospital from 2007-2009. We assessed model discrimination using the area under the receiver operating characteristic curve (AUC) and assessed calibration by comparing the ratio of observed-to-expected (O/E) cases. We calculated the square root of the Brier Score and positive and negative predictive values of each model. Results Our results confirmed good calibration and comparable moderate discrimination of the BRCAPRO, Gail, Tyrer-Cuzick, and BCSC models. The Gail model had slightly better O/E ratio and AUC (O/E=0.98, 95% CI:0.91-1.06, AUC=0.64, 95% CI:0.61-0.65) than BRCAPRO (O/E=0.94, 95% CI:0.88-1.02, AUC=0.61, 95% CI:0.59-0.63) and Tyrer-Cuzick (version 8, O/E=0.84, 95% CI:0.79-0.91, AUC=0.62, 95% CI:0.60-0.64) in the full study population, and the BCSC model had the highest AUC among women with available breast density information (O/E=0.97, 95% CI:0.89-1.05, AUC=0.64, 95% CI:0.62-0.66). All models had poorer predictive accuracy for HER2+ and triple negative breast cancers than hormone receptor positive HER2- breast cancers. Conclusions In a large cohort of patients undergoing mammography screening, existing risk prediction models had similar, moderate predictive accuracy and good calibration overall. Models that incorporate additional genetic and non-genetic risk factors and estimate risk of tumor subtypes may further improve breast cancer risk prediction.

[1]  Melissa Bondy,et al.  Projecting individualized absolute invasive breast cancer risk in African American women. , 2007, Journal of the National Cancer Institute.

[2]  Giovanni Parmigiani,et al.  Simplifying clinical use of the genetic risk prediction model BRCAPRO , 2013, Breast Cancer Research and Treatment.

[3]  R. Tamimi,et al.  Established breast cancer risk factors and risk of intrinsic tumor subtypes. , 2015, Biochimica et biophysica acta.

[4]  N. Risch,et al.  Autosomal dominant inheritance of early‐onset breast cancer. Implications for risk prediction , 1994 .

[5]  Danielle Braun,et al.  Breast cancer risk models: a comprehensive overview of existing models, validation, and clinical applications , 2017, Breast Cancer Research and Treatment.

[6]  G. Anderson,et al.  Predicting risk of breast cancer in postmenopausal women by hormone receptor status. , 2007, Journal of the National Cancer Institute.

[7]  Gord Glendon,et al.  10-year performance of four models of breast cancer risk: a validation study. , 2019, The Lancet. Oncology.

[8]  Mitchell H Gail,et al.  Projecting Individualized Absolute Invasive Breast Cancer Risk in US Hispanic Women , 2017, Journal of the National Cancer Institute.

[9]  M. Gail,et al.  Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. , 1989, Journal of the National Cancer Institute.

[10]  D. Easton,et al.  The BOADICEA model of genetic susceptibility to breast and ovarian cancer , 2004, British Journal of Cancer.

[11]  N. Risch,et al.  The calculation of breast cancer risk for women with a first degree family history of ovarian cancer , 1993, Breast Cancer Research and Treatment.

[12]  D. Bowen,et al.  Comparisons of two breast cancer risk estimates in women with a family history of breast cancer. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[13]  N Risch,et al.  Genetic analysis of breast cancer in the cancer and steroid hormone study. , 1991, American journal of human genetics.

[14]  G. Giles,et al.  Breast Cancer Risk Prediction Using Clinical Models and 77 Independent Risk-Associated SNPs for Women Aged Under 50 Years: Australian Breast Cancer Family Registry , 2015, Cancer Epidemiology, Biomarkers & Prevention.

[15]  Konstantin Strauch,et al.  Breast cancer risk assessment across the risk continuum: genetic and nongenetic risk factors contributing to differential model performance , 2012, Breast Cancer Research.

[16]  Ammarin Thakkinstian,et al.  Risk prediction models of breast cancer: a systematic review of model performances , 2012, Breast Cancer Research and Treatment.

[17]  Jack Cuzick,et al.  Long-term Accuracy of Breast Cancer Risk Assessment Combining Classic Risk Factors and Breast Density , 2018, JAMA oncology.

[18]  M. García-Closas,et al.  Comparative validation of breast cancer risk prediction models and projections for future risk stratification , 2018, bioRxiv.

[19]  D Spiegelman,et al.  Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention. , 2001, Journal of the National Cancer Institute.

[20]  Stephen W Duffy,et al.  A breast cancer prediction model incorporating familial and personal risk factors , 2004, Hereditary Cancer in Clinical Practice.

[21]  Susan M. Astley,et al.  Mammographic density adds accuracy to both the Tyrer-Cuzick and Gail breast cancer risk models in a prospective UK screening cohort , 2015, Breast Cancer Research.

[22]  Karla Kerlikowske,et al.  Using Clinical Factors and Mammographic Breast Density to Estimate Breast Cancer Risk: Development and Validation of a New Predictive Model , 2008, Annals of Internal Medicine.

[23]  Assessment of performance of the Gail model for predicting breast cancer risk: a systematic review and meta-analysis with trial sequential analysis , 2018, Breast Cancer Research.

[24]  Mitchell H Gail,et al.  Projecting individualized absolute invasive breast cancer risk in Asian and Pacific Islander American women. , 2011, Journal of the National Cancer Institute.

[25]  D. Berry,et al.  Probability of carrying a mutation of breast-ovarian cancer gene BRCA1 based on family history. , 1997, Journal of the National Cancer Institute.

[26]  A Howell,et al.  Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme , 2003, Journal of medical genetics.